57 related articles for article (PubMed ID: 21821029)
1. Aurora-A phosphorylates hnRNPK and disrupts its interaction with p53.
Hsueh KW; Fu SL; Huang CY; Lin CH
FEBS Lett; 2011 Sep; 585(17):2671-5. PubMed ID: 21821029
[TBL] [Abstract][Full Text] [Related]
2. Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation.
Rong R; Jiang LY; Sheikh MS; Huang Y
Oncogene; 2007 Dec; 26(55):7700-8. PubMed ID: 17563743
[TBL] [Abstract][Full Text] [Related]
3. A novel Aurora-A-mediated phosphorylation of p53 inhibits its interaction with MDM2.
Hsueh KW; Fu SL; Chang CB; Chang YL; Lin CH
Biochim Biophys Acta; 2013 Feb; 1834(2):508-15. PubMed ID: 23201157
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
5. Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation.
Temme A; Geiger KD; Wiedemuth R; Conseur K; Pietsch T; Felsberg J; Reifenberger G; Tatsuka M; Hagel C; Westphal M; Berger H; Simon M; Weller M; Schackert G
J Neuropathol Exp Neurol; 2010 Jun; 69(6):632-42. PubMed ID: 20467329
[TBL] [Abstract][Full Text] [Related]
6. Aurora-A overexpression in mouse liver causes p53-dependent premitotic arrest during liver regeneration.
Li CC; Chu HY; Yang CW; Chou CK; Tsai TF
Mol Cancer Res; 2009 May; 7(5):678-88. PubMed ID: 19435814
[TBL] [Abstract][Full Text] [Related]
7. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
Zeng PY; Berger SL
Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
[TBL] [Abstract][Full Text] [Related]
8. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
9. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.
Hu MC; Qiu WR; Wang YP
Oncogene; 1997 Nov; 15(19):2277-87. PubMed ID: 9393873
[TBL] [Abstract][Full Text] [Related]
10. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53.
Turenne GA; Paul P; Laflair L; Price BD
Oncogene; 2001 Aug; 20(37):5100-10. PubMed ID: 11526498
[TBL] [Abstract][Full Text] [Related]
11. DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage.
Jimenez GS; Bryntesson F; Torres-Arzayus MI; Priestley A; Beeche M; Saito S; Sakaguchi K; Appella E; Jeggo PA; Taccioli GE; Wahl GM; Hubank M
Nature; 1999 Jul; 400(6739):81-3. PubMed ID: 10403253
[TBL] [Abstract][Full Text] [Related]
12. Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9.
Arai S; Matsushita A; Du K; Yagi K; Okazaki Y; Kurokawa R
FEBS Lett; 2007 Dec; 581(29):5649-57. PubMed ID: 18022393
[TBL] [Abstract][Full Text] [Related]
13. MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
Huck JJ; Zhang M; McDonald A; Bowman D; Hoar KM; Stringer B; Ecsedy J; Manfredi MG; Hyer ML
Mol Cancer Res; 2010 Mar; 8(3):373-84. PubMed ID: 20197380
[TBL] [Abstract][Full Text] [Related]
14. Aurora-C interacts with and phosphorylates the transforming acidic coiled-coil 1 protein.
Gabillard JC; Ulisse S; Baldini E; Sorrenti S; Cremet JY; Coccaro C; Prigent C; D'Armiento M; Arlot-Bonnemains Y
Biochem Biophys Res Commun; 2011 May; 408(4):647-53. PubMed ID: 21531210
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of p53 is regulated by TPX2-Aurora A in xenopus oocytes.
Pascreau G; Eckerdt F; Lewellyn AL; Prigent C; Maller JL
J Biol Chem; 2009 Feb; 284(9):5497-505. PubMed ID: 19121998
[TBL] [Abstract][Full Text] [Related]
16. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.
Liu Q; Kaneko S; Yang L; Feldman RI; Nicosia SV; Chen J; Cheng JQ
J Biol Chem; 2004 Dec; 279(50):52175-82. PubMed ID: 15469940
[TBL] [Abstract][Full Text] [Related]
17. Functional significance of Aurora kinase A regulatory interactions with p53-ERĪ± complex in human breast cancer cells.
Katayama H; Sen S
Horm Cancer; 2011 Apr; 2(2):117-24. PubMed ID: 21761334
[TBL] [Abstract][Full Text] [Related]
18. Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53.
Warnock LJ; Raines SA; Milner J
Cancer Biol Ther; 2011 Dec; 12(12):1059-68. PubMed ID: 22157150
[TBL] [Abstract][Full Text] [Related]
19. Aurora B interacts with NIR-p53, leading to p53 phosphorylation in its DNA-binding domain and subsequent functional suppression.
Wu L; Ma CA; Zhao Y; Jain A
J Biol Chem; 2011 Jan; 286(3):2236-44. PubMed ID: 20959462
[TBL] [Abstract][Full Text] [Related]
20. Aurora B kinase phosphorylates and instigates degradation of p53.
Gully CP; Velazquez-Torres G; Shin JH; Fuentes-Mattei E; Wang E; Carlock C; Chen J; Rothenberg D; Adams HP; Choi HH; Guma S; Phan L; Chou PC; Su CH; Zhang F; Chen JS; Yang TY; Yeung SC; Lee MH
Proc Natl Acad Sci U S A; 2012 Jun; 109(24):E1513-22. PubMed ID: 22611192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
